Relapsed or refractory hodgkin lymphoma

Dilemmas in balancing the risks and benefits of therapeutic modalities

Leonard Tuanquin, Ronald C. McGarry

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
JournalAmerican Journal of Hematology/ Oncology
Volume8
Issue number7
StatePublished - Jul 2009

Fingerprint

Hodgkin Disease
Therapeutics

All Science Journal Classification (ASJC) codes

  • Oncology

Cite this

@article{56de4362bb9d4f17af850619a0479171,
title = "Relapsed or refractory hodgkin lymphoma: Dilemmas in balancing the risks and benefits of therapeutic modalities",
author = "Leonard Tuanquin and McGarry, {Ronald C.}",
year = "2009",
month = "7",
language = "English (US)",
volume = "8",
journal = "American Journal of Oncology Review",
issn = "1939-6163",
publisher = "U. S. Healthcare Communications LLC",
number = "7",

}

TY - JOUR

T1 - Relapsed or refractory hodgkin lymphoma

T2 - Dilemmas in balancing the risks and benefits of therapeutic modalities

AU - Tuanquin, Leonard

AU - McGarry, Ronald C.

PY - 2009/7

Y1 - 2009/7

UR - http://www.scopus.com/inward/record.url?scp=73249128638&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73249128638&partnerID=8YFLogxK

M3 - Comment/debate

VL - 8

JO - American Journal of Oncology Review

JF - American Journal of Oncology Review

SN - 1939-6163

IS - 7

ER -